Population
Patients with Antithrombin III (AT III) deficiency
Design
Case_report
Authors
Loading...
Prompts consideration of AT III deficiency in venous thromboembolism; leaves open optimal treatment strategies pending controlled studies.
Provides a clinical overview of Antithrombin III deficiency, highlighting its role as a risk factor for venous thrombosis and outlining treatment strategies including AT III concentrates and heparin.
Găman et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: